-
Je něco špatně v tomto záznamu ?
Treatment of Active Crohn's Disease With Exclusive Enteral Nutrition Diminishes the Immunostimulatory Potential of Fecal Microbial Products
C. Kerbiriou, C. Dickson, B. Nichols, M. Logan, A. Mascellani, J. Havlik, RK. Russell, R. Hansen, S. Milling, K. Gerasimidis
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
Glasgow Children's Hospital Charity
, Nestlé Health Science
PubMed
38982655
DOI
10.1093/ibd/izae124
Knihovny.cz E-zdroje
- MeSH
- Crohnova nemoc * terapie mikrobiologie imunologie MeSH
- dítě MeSH
- enterální výživa * metody MeSH
- feces * mikrobiologie chemie MeSH
- leukocytární L1-antigenní komplex * analýza MeSH
- leukocyty mononukleární imunologie metabolismus MeSH
- lidé MeSH
- mladiství MeSH
- střevní mikroflóra * MeSH
- TNF-alfa * metabolismus MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Exclusive enteral nutrition (EEN) is an effective treatment for active Crohn's disease (CD). This study explored the immunostimulatory potential of a cell-free fecal filtrate and related this with changes in the fecal microbiota and metabolites in children with active CD undertaking treatment with EEN. METHODS: Production of tumor necrosis factor α (TNFα) from peripheral blood mononuclear cells was measured following their stimulation with cell-free fecal slurries from children with CD, before, during, and at completion of EEN. The metabolomic profile of the feces used was quantified using proton nuclear magnetic resonance and their microbiota composition with 16S ribosomal RNA sequencing. RESULTS: Following treatment with EEN, 8 (72%) of 11 patients demonstrated a reduction in fecal calprotectin (FC) >50% and were subsequently labeled FC responders. In this subgroup, TNFα production from peripheral blood mononuclear cells was reduced during EEN (P = .008) and reached levels like healthy control subjects. In parallel to these changes, the fecal concentrations of acetate, butyrate, propionate, choline, and uracil significantly decreased in FC responders, and p-cresol significantly increased. At EEN completion, TNFα production from peripheral blood mononuclear cells was positively correlated with butyrate (rho = 0.70; P = .016). Microbiota structure (β diversity) was influenced by EEN treatment, and a total of 28 microbial taxa changed significantly in fecal calprotectin responders. At EEN completion, TNFα production positively correlated with the abundance of fiber fermenters from Lachnospiraceae_UCG-004 and Faecalibacterium prausnitzii and negatively with Hungatella and Eisenbergiella tayi. CONCLUSIONS: This study offers proof-of concept data to suggest that the efficacy of EEN may result from modulation of diet-dependent microbes and their products that cause inflammation in patients with CD.
Department of Food Science Czech University of Life Sciences Prague Prague Czech Republic
School of Infection and Immunity University of Glasgow Glasgow United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003083
- 003
- CZ-PrNML
- 005
- 20250206104033.0
- 007
- ta
- 008
- 250121s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/ibd/izae124 $2 doi
- 035 __
- $a (PubMed)38982655
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kerbiriou, Caroline $u Human Nutrition, School of Medicine, Dentistry and Nursing, Glasgow Royal Infirmary, University of Glasgow, Glasgow, United Kingdom
- 245 10
- $a Treatment of Active Crohn's Disease With Exclusive Enteral Nutrition Diminishes the Immunostimulatory Potential of Fecal Microbial Products / $c C. Kerbiriou, C. Dickson, B. Nichols, M. Logan, A. Mascellani, J. Havlik, RK. Russell, R. Hansen, S. Milling, K. Gerasimidis
- 520 9_
- $a BACKGROUND: Exclusive enteral nutrition (EEN) is an effective treatment for active Crohn's disease (CD). This study explored the immunostimulatory potential of a cell-free fecal filtrate and related this with changes in the fecal microbiota and metabolites in children with active CD undertaking treatment with EEN. METHODS: Production of tumor necrosis factor α (TNFα) from peripheral blood mononuclear cells was measured following their stimulation with cell-free fecal slurries from children with CD, before, during, and at completion of EEN. The metabolomic profile of the feces used was quantified using proton nuclear magnetic resonance and their microbiota composition with 16S ribosomal RNA sequencing. RESULTS: Following treatment with EEN, 8 (72%) of 11 patients demonstrated a reduction in fecal calprotectin (FC) >50% and were subsequently labeled FC responders. In this subgroup, TNFα production from peripheral blood mononuclear cells was reduced during EEN (P = .008) and reached levels like healthy control subjects. In parallel to these changes, the fecal concentrations of acetate, butyrate, propionate, choline, and uracil significantly decreased in FC responders, and p-cresol significantly increased. At EEN completion, TNFα production from peripheral blood mononuclear cells was positively correlated with butyrate (rho = 0.70; P = .016). Microbiota structure (β diversity) was influenced by EEN treatment, and a total of 28 microbial taxa changed significantly in fecal calprotectin responders. At EEN completion, TNFα production positively correlated with the abundance of fiber fermenters from Lachnospiraceae_UCG-004 and Faecalibacterium prausnitzii and negatively with Hungatella and Eisenbergiella tayi. CONCLUSIONS: This study offers proof-of concept data to suggest that the efficacy of EEN may result from modulation of diet-dependent microbes and their products that cause inflammation in patients with CD.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a Crohnova nemoc $x terapie $x mikrobiologie $x imunologie $7 D003424
- 650 12
- $a feces $x mikrobiologie $x chemie $7 D005243
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a enterální výživa $x metody $7 D004750
- 650 12
- $a střevní mikroflóra $7 D000069196
- 650 12
- $a TNF-alfa $x metabolismus $7 D014409
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a mladiství $7 D000293
- 650 12
- $a leukocytární L1-antigenní komplex $x analýza $7 D039841
- 650 _2
- $a leukocyty mononukleární $x imunologie $x metabolismus $7 D007963
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dickson, Caitlin $u Human Nutrition, School of Medicine, Dentistry and Nursing, Glasgow Royal Infirmary, University of Glasgow, Glasgow, United Kingdom
- 700 1_
- $a Nichols, Ben $u Human Nutrition, School of Medicine, Dentistry and Nursing, Glasgow Royal Infirmary, University of Glasgow, Glasgow, United Kingdom
- 700 1_
- $a Logan, Michael $u Human Nutrition, School of Medicine, Dentistry and Nursing, Glasgow Royal Infirmary, University of Glasgow, Glasgow, United Kingdom
- 700 1_
- $a Mascellani, Anna $u Department of Food Science, Czech University of Life Sciences Prague, Prague, Czech Republic
- 700 1_
- $a Havlik, Jaroslav $u Department of Food Science, Czech University of Life Sciences Prague, Prague, Czech Republic
- 700 1_
- $a Russell, Richard K $u Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Sick Children and Young People, Edinburgh, United Kingdom
- 700 1_
- $a Hansen, Richard $u Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, United Kingdom $u Division of Clinical and Molecular Medicine, Department of Child Health, School of Medicine, University of Dundee, Dundee, United Kingdom
- 700 1_
- $a Milling, Simon $u School of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom $1 https://orcid.org/0000000343845516
- 700 1_
- $a Gerasimidis, Konstantinos $u Human Nutrition, School of Medicine, Dentistry and Nursing, Glasgow Royal Infirmary, University of Glasgow, Glasgow, United Kingdom $1 https://orcid.org/0000000194322200
- 773 0_
- $w MED00002243 $t Inflammatory bowel diseases $x 1536-4844 $g Roč. 30, č. 12 (2024), s. 2457-2466
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38982655 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104029 $b ABA008
- 999 __
- $a ok $b bmc $g 2263072 $s 1239090
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 30 $c 12 $d 2457-2466 $e 20241205 $i 1536-4844 $m Inflammatory bowel diseases $n Inflamm Bowel Dis $x MED00002243
- GRA __
- $p Glasgow Children's Hospital Charity
- GRA __
- $p , Nestlé Health Science
- LZP __
- $a Pubmed-20250121